St. Petersburg State Pavlov Medical University
pavlovmed.ruLive pipeline data from ClinicalTrials.gov, refreshed daily.
Total trials
51
Active
13
Phase 3
0
Total enrollment
8,976
Pipeline matrix
Showing 18 of 18 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|---|---|---|---|---|---|---|
| Nivolumab | — | — | — | — | — | 8 | |
| Ruxolitinib | — | — | — | — | — | 6 | |
| Bendamustine Hydrochloride | — | — | — | — | — | 5 | |
| Abatacept | — | — | — | — | — | 1 | |
| Nivo-AVD | — | — | — | — | — | 1 | |
| BEACOPP-like | — | — | — | — | — | 1 | |
| Nivolumab, Pembrolizumab | — | — | — | — | — | 1 | |
| Vitamin A | — | — | — | — | — | 1 | |
| Vitamin D3 | — | — | — | — | — | 1 | |
| Sorafenib | — | — | — | — | — | 1 | |
| Fludarabine Phosphate for | — | — | — | — | — | 1 | |
| 5-Fluorouracil | — | — | — | — | — | 1 | |
| Leucovorin | — | — | — | — | — | 1 | |
| Oxaliplatin | — | — | — | — | — | 1 | |
| Docetaxel | — | — | — | — | — | 1 | |
| Adjuvant chemotherapy | — | — | — | — | — | 1 | |
| Immunosuppressive treatment | — | — | — | — | — | 1 | |
| anesthesia of the respiratory tract with lidocaine | — | — | — | — | — | 1 |
Next readouts
- 2021-10-10
- 2025-10-01
- 2026-03-10
- 2026-05
- 2026-06-01
- 2026-12-10
- 2027-01-01
- 2027-05
- 2028-06
- 2029-05
Top conditions
- Myelodysplastic Syndromes7
- Acute Myeloid Leukemia5
- Hodgkin Lymphoma5
- Ischemic Heart Disease4
- Urolithiasis4
- Chronic Myeloid Leukemia4
- Myeloproliferative Neoplasm4
- Multiple Sclerosis3
Frequently asked questions about St. Petersburg State Pavlov Medical University
- How many clinical trials does St. Petersburg State Pavlov Medical University have on ClinicalTrials.gov?
- St. Petersburg State Pavlov Medical University is listed as the lead sponsor on 51 clinical trials in ClinicalTrials.gov, 13 of which are currently active (recruiting, enrolling, or ongoing).
- How many of St. Petersburg State Pavlov Medical University's trials are in Phase 3?
- 0 of St. Petersburg State Pavlov Medical University's trials are in Phase 3, spread across 18 active drug programs.
- What therapeutic areas does St. Petersburg State Pavlov Medical University focus on?
- St. Petersburg State Pavlov Medical University's most-studied conditions on ClinicalTrials.gov are Myelodysplastic Syndromes, Acute Myeloid Leukemia, Hodgkin Lymphoma, Ischemic Heart Disease, Urolithiasis.
- When are St. Petersburg State Pavlov Medical University's next clinical trial readouts?
- St. Petersburg State Pavlov Medical University has 10 upcoming primary-completion readouts tracked here; the soonest is “Oncological Benefits of Pressured Intraperitoneal Aerosol Chemotherapy (PIPAC) in Patients With T3-4 Gastric Cancer Cyt-”, expected around 2021-10-10.